Intensified fed-batch (IFB) processing can improve upstream productivity, but process conditions that work well for one cell line may not translate directly to another.
This whitepaper explores how Samsung Biologics has advanced S-Tensify™, its intensified fed-batch platform, toward a more tailored, cell-line-specific approach. By fine-tuning media utilization, feeding strategies, inoculation density, and culture duration, the platform supports opportunities to reduce media consumption and increase titer across different cell-line scenarios.
Key highlights include:
- Cell-line-specific optimization of media utilization and feeding strategies
- Adjustments to inoculation density and culture duration based on cell-line behavior
- Improved media efficiency and increased titer through whole-process optimization
Discover how the continued evolution of S-Tensify™ enables greater flexibility in balancing productivity, process efficiency, and cost of goods across diverse biologics programs.
Intensified fed-batch (IFB) processing can improve upstream productivity, but process conditions that work well for one cell line may not translate directly to another.
This whitepaper explores how Samsung Biologics has advanced S-Tensify™, its intensified fed-batch platform, toward a more tailored, cell-line-specific approach. By fine-tuning media utilization, feeding strategies, inoculation density, and culture duration, the platform supports opportunities to reduce media consumption and increase titer across different cell-line scenarios.
Key highlights include:
- Cell-line-specific optimization of media utilization and feeding strategies
- Adjustments to inoculation density and culture duration based on cell-line behavior
- Improved media efficiency and increased titer through whole-process optimization
Discover how the continued evolution of S-Tensify™ enables greater flexibility in balancing productivity, process efficiency, and cost of goods across diverse biologics programs.
Related Content